From October 6–9, 2026, Jwana Akawe, Product Manager, and Braah Krayem, Product Specialist, represented Initia at the International Continence Society (ICS) 2026 Annual Meeting in Maastricht, the Netherlands.

The meeting brought together urologists, urogynecologists, physiotherapists, researchers, and other specialists from around the world to exchange knowledge and discuss emerging approaches in continence and pelvic health.

Showcasing MORENOVA at ICS 2026

Throughout the conference, the Initia team presented the MORENOVA platform and its potential applications across women’s health, men’s health, and pelvic health through Low-Intensity Extracorporeal Shockwave Therapy (Li-ESWT).

The event provided an important opportunity to discuss clinical needs, treatment approaches, and the evolving role of shockwave technology with specialists actively engaged in pelvic health practice and research.

Scientific Research and Clinical Innovation

Scientific research and clinical innovation were central themes at ICS 2026. Contributions from Dr. Giulia Duarte Loureiro and Dr. Yuta Anno highlighted ongoing research and clinical interest in shockwave therapy and its potential applications.

These discussions reflected the growing scientific attention around non-invasive technologies and the importance of continued clinical evaluation, evidence generation, and multidisciplinary collaboration.

Advancing International Collaboration

ICS 2026 also created valuable opportunities to exchange clinical insights with healthcare professionals and researchers from different markets, while exploring possibilities for future research and international collaboration.

Initia thanks the International Continence Society, Juntendo University Urayasu Hospital, and everyone who visited the booth and engaged with the team. We look forward to continuing these conversations and supporting evidence-based innovation in pelvic health.